OVID compared with EQ: revenue, margins and what each company keeps, and the suppliers and customers both name

OVIDOvid Therapeutics Inc.

Mkt capRevenueRevenue

EQEquillium, Inc.

Mkt capRevenueRevenue

Compare

OVIDOvid Therapeutics Inc.

EQEquillium, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

OVID, solidEQ, dashed

Supply-chain overlap

Revenue flow

OVID: latest quarter is a loss; flow not drawable. EQ: latest quarter is a loss; flow not drawable.Method ›

OVIDOvid Therapeutics Inc.

2.55▼−0.45%· post 2.54

Mkt cap$496.1MRevenue$733,000Q2 FY26Revenue$7MFY25

EQEquillium, Inc.

1.38▼−2.90%· post 1.38

ClosedOct 30 '26

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

Compare

ClosedOct 30 '26

OVIDOvid Therapeutics Inc.

EQEquillium, Inc.

2.55▼−0.45%post 2.54

Price

1.38▼−2.90%post 1.38

$496.1M

Mkt cap

$86.9M

Q2 FY26$733,000

Revenue

$4MQ4 FY24

FY25$7M

Revenue

$41MFY24

OVID2.55▼−0.45%vsEQ1.38▼−2.90%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only OVID 7

LGNDLigand Pharmaceuticalscustomer

TAKTakedacustomer

—Northwestern Universityunlistedsupplier

—AstraZenecaunlistedsupplier

3 more · OVID chain ›

Shared 0

No shared counterparties.

Only EQ 2

—Bioconunlistedsupplier

—Ono Pharmaceuticalunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR